2023
Multicenter study of the natural history and therapeutic responses of patients with chikungunya, focusing on acute and chronic musculoskeletal manifestations – a study protocol from the clinical and applied research in Chikungunya (REPLICK network)
da Silva Duarte G, Jones A, de Goes Cavalcanti L, de Melo Rêgo M, Ribeiro G, Boyton R, Pereira D, Croda J, Costa F, Duarte A, Consolaro M, Stabeli R, Negrão F, Proenca-Modena J, Villalobos-Salcedo J, da Rocha Castelar Pinheiro G, de Barros Albuquerque A, de Almeida Barreto F, Moreira J, Ferrari I, Évora P, da Silva V, Lacerda M, Altmann D, Siqueira A. Multicenter study of the natural history and therapeutic responses of patients with chikungunya, focusing on acute and chronic musculoskeletal manifestations – a study protocol from the clinical and applied research in Chikungunya (REPLICK network). BMC Infectious Diseases 2023, 23: 499. PMID: 37507666, PMCID: PMC10386654, DOI: 10.1186/s12879-023-08292-y.Peer-Reviewed Original ResearchConceptsMusculoskeletal manifestationsStudy protocolTherapeutic responseChronic diseasesNatural historyDestructive disease courseMulticenter cohort studyLong-term sequelaeAssociated risk factorsClinical report formsClinical trial designQuality of lifeAliquots of bloodCohort studyCHIKV infectionDisease courseChronic painSymptomatic infectionBlood testsHigh morbidityMulticenter studyMusculoskeletal symptomsTherapeutic guidelinesClinical spectrumPatient cohortEstimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination
Fitzpatrick M, Moghadas S, Vilches T, Shah A, Pandey A, Galvani A. Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination. JAMA Network Open 2023, 6: e2313586. PMID: 37204795, PMCID: PMC10199352, DOI: 10.1001/jamanetworkopen.2023.13586.Peer-Reviewed Original ResearchConceptsBooster campaignBooster vaccinationInfluenza vaccinationPediatric populationDecision analytical modelSchool absenteeismIntensive carePediatric hospitalizationsEligible individualsMAIN OUTCOMEAge groupsIntensive care unit admissionCare unit admissionSeasonal influenza vaccinationCOVID-19 illnessCOVID-19 prevention strategiesEligible age groupDecreased hospitalizationsUnit admissionCOVID-19 transmissionSymptomatic infectionAdverse outcomesIsolation daysHospitalizationGeneral population
2022
Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel
Prunas O, Weinberger D, Pitzer V, Gazit S, Patalon T. Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel. Clinical Infectious Diseases 2022, 76: 113-118. PMID: 36484301, PMCID: PMC10202431, DOI: 10.1093/cid/ciac315.Peer-Reviewed Original ResearchConceptsMaccabi Healthcare ServicesBNT162b2 vaccineSecond doseAcute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSyndrome coronavirus 2 infectionPositive polymerase chain reaction testSARS-CoV-2 infectionPfizer BNT162b2 vaccineCoronavirus 2 infectionVaccine-induced immunityVaccine-induced protectionPolymerase chain reaction testIncidence of infectionCoronavirus disease 2019COVID-19Chain reaction testShort-term effectivenessCase-control designLong-term effectivenessVaccine effectivenessSymptomatic infectionLong-term protectionDisease 2019Delta variantInsights into Plasmodium vivax Asymptomatic Malaria Infections and Direct Skin-Feeding Assays to Assess Onward Malaria Transmission in the Amazon.
Moreno M, Torres K, Tong C, García Castillo SS, Carrasco-Escobar G, Guedez G, Torres L, Herrera-Varela M, Guerra L, Guzman-Guzman M, Wong D, Ramirez R, Llanos-Cuentas A, Conn JE, Gamboa D, Vinetz JM. Insights into Plasmodium vivax Asymptomatic Malaria Infections and Direct Skin-Feeding Assays to Assess Onward Malaria Transmission in the Amazon. American Journal Of Tropical Medicine And Hygiene 2022, 107: 154-161. PMID: 35895359, PMCID: PMC9294676, DOI: 10.4269/ajtmh.21-1217.Peer-Reviewed Original ResearchConceptsDirect skin feeding assaysMalaria infectionP. vivax malaria infectionsAsymptomatic malaria infectionsVivax malaria infectionMosquito feeding assaysDiverse epidemiological settingsCohort studySymptomatic infectionAsymptomatic individualsAsymptomatic infectionSymptomatic participantsParasite carriersPlasmodium vivaxEpidemiological settingsMalaria transmissionPlasmodium gametocytesInfectionMajor mosquito vectorsDisease transmissibilityParasite infectionLongitudinal studyMosquito vectorsInfection intensityInfectivityEffectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
Cerqueira-Silva T, Andrews JR, Boaventura VS, Ranzani OT, de Araújo Oliveira V, Paixão ES, Júnior JB, Machado TM, Hitchings MDT, Dorion M, Lind ML, Penna GO, Cummings DAT, Dean NE, Werneck GL, Pearce N, Barreto ML, Ko AI, Croda J, Barral-Netto M. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. The Lancet Infectious Diseases 2022, 22: 791-801. PMID: 35366959, PMCID: PMC8971277, DOI: 10.1016/s1473-3099(22)00140-2.Peer-Reviewed Original ResearchConceptsPrevious SARS-CoV-2 infectionSARS-CoV-2 infectionChAdOx1 nCoV-19Negative RT-PCR testRT-PCR testVaccine series completionCase-control studySymptomatic infectionCOVID-19 vaccineNCoV-19Symptomatic illnessVaccine seriesSecond doseSevere outcomesSeries completionTwo-dose vaccine seriesPositive RT-PCR testInitial SARS-CoV-2 infectionMultivariable conditional logistic regressionCOVID-19Effectiveness of CoronaVacFull vaccine seriesMore daysOdds of hospitalisationSymptomatic COVID-19
2020
Clinical Characteristics of Asymptomatic and Symptomatic Pediatric Coronavirus Disease 2019 (COVID-19): A Systematic Review
Yoon S, Li H, Lee K, Hong S, Kim D, Im H, Rah W, Kim E, Cha S, Yang J, Kronbichler A, Kresse D, Koyanagi A, Jacob L, Ghayda R, Shin J, Smith L. Clinical Characteristics of Asymptomatic and Symptomatic Pediatric Coronavirus Disease 2019 (COVID-19): A Systematic Review. Medicina 2020, 56: 474. PMID: 32942705, PMCID: PMC7558873, DOI: 10.3390/medicina56090474.Peer-Reviewed Original ResearchConceptsPediatric COVID-19Clinical characteristicsSymptomatic infectionChest CT scan findingsAssociated with symptomatic infectionPediatric COVID-19 patientsOlder pediatric patientsAbnormal chest CTCT scan findingsPediatric coronavirus diseasePediatric COVID-19 casesAsymptomatic COVID-19COVID-19 patientsChest CTMeta-Analysis guidelinesScan findingsPediatric patientsInfected childrenRadiological characteristicsYounger patientsClinical findingsCase reportSymptomatic childrenOlder patientsPreferred Reporting Items
2018
Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis
Cahill ME, Conley S, DeWan AT, Montgomery RR. Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis. BMC Infectious Diseases 2018, 18: 282. PMID: 29929468, PMCID: PMC6014009, DOI: 10.1186/s12879-018-3186-6.Peer-Reviewed Original ResearchConceptsWest Nile virus diseaseSevere diseaseVirus diseaseWest Nile virus infectionGenetic factorsGenetic variantsSevere disease outcomesPotential therapeutic interventionsGenetic risk factorsAdditional genetic factorsWest Nile virusMinority of individualsSymptomatic infectionAsymptomatic infectionMechanisms of resistanceRisk factorsImmune mechanismsInitial symptomsDisease outcomeVirus infectionImmune responseDengue diseaseDisease pathogenesisTherapeutic interventionsSystematic review
2017
Differences in Prevalence of Symptomatic Zika Virus Infection, by Age and Sex—Puerto Rico, 2016
Lozier MJ, Burke RM, Lopez J, Acevedo V, Amador M, Read JS, Jara A, Waterman SH, Barrera R, Muñoz-Jordan J, Rivera-Garcia B, Sharp TM. Differences in Prevalence of Symptomatic Zika Virus Infection, by Age and Sex—Puerto Rico, 2016. The Journal Of Infectious Diseases 2017, 217: 1678-1689. PMID: 29216376, PMCID: PMC8849542, DOI: 10.1093/infdis/jix630.Peer-Reviewed Original ResearchConceptsZIKV infectionReverse transcription-polymerase chain reactionEnzyme-linked immunosorbent assaySex-dependent differencesSymptomatic infectionFemale sexSymptomatic Zika virus infectionZika virus infectionSymptomatic ZIKV infectionZika virus diseaseTranscription-polymerase chain reactionNonpregnant womenResidents of householdsZIKV diseaseRecent illnessVirus infectionDisease casesDiagnostic testingStudy participantsInfectionImmunosorbent assayConvenience samplePotential mechanismsChain reactionAgeThe natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection
Yao Y, Strauss-Albee DM, Zhou JQ, Malawista A, Garcia MN, Murray KO, Blish CA, Montgomery RR. The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection. PLOS ONE 2017, 12: e0172625. PMID: 28235099, PMCID: PMC5325267, DOI: 10.1371/journal.pone.0172625.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsAgedAged, 80 and overAntigens, CDAsymptomatic DiseasesFemaleGene Expression RegulationHumansImmunity, InnateImmunophenotypingInterferon-gammaKiller Cells, NaturalLymphocyte ActivationLymphocyte CountMiddle AgedNatural Cytotoxicity Triggering Receptor 1Natural Cytotoxicity Triggering Receptor 2Natural Cytotoxicity Triggering Receptor 3NK Cell Lectin-Like Receptor Subfamily CNK Cell Lectin-Like Receptor Subfamily KPrimary Cell CultureSeverity of Illness IndexWest Nile FeverWest Nile virusConceptsNK cell subsetsNK cellsWest Nile virusWNV infectionCell subsetsCell responsesSpecific NK cell subsetsNatural killer cell responsesInnate NK cellsSevere neuroinvasive diseaseNK cell responsesNK cell receptorsNile virusHuman WNV infectionsImmune pathogenesisNK repertoirePolyfunctional responsesMore IFNSymptomatic infectionChemokine secretionAsymptomatic infectionNeuroinvasive diseasePrior historyCytolytic activityInfection
2000
Lyme Disease
Shapiro E, Gerber M. Lyme Disease. Clinical Infectious Diseases 2000, 31: 533-542. PMID: 10987718, DOI: 10.1086/313982.Peer-Reviewed Original ResearchConceptsLyme diseaseCommon vector borne diseaseSeventh cranial nerve palsyOnly nonspecific symptomsCranial nerve palsyAnnular rashNerve palsyNonspecific symptomsAseptic meningitisSymptomatic infectionFrequent manifestationCommon causeActual morbidityPossible diagnosisSerological testsMost personsDiseaseBorrelia burgdorferiSymptomsVector borne diseasesBorne diseasesFrequent useManifestationsUnited StatesCause
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply